Medicenna Therapeutics (MDNA) News Today Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 24 at 12:02 PM | theglobeandmail.comClosing Bell: Medicenna Therapeutics Corp flat on Tuesday (MDNA)May 26, 2024 | finance.yahoo.comMedicenna Therapeutics Corp. (MDNA.TO)May 13, 2024 | seekingalpha.comMDNA:CA Medicenna Therapeutics Corp.May 10, 2024 | investing.comMedicenna Therapeutics Corp (MDNA)April 30, 2024 | finance.yahoo.comMedicenna Therapeutics Announces Closing of CA$20 Million Investment from RA Capital ManagementApril 24, 2024 | finanznachrichten.deMedicenna Therapeutics Corp.: Medicenna Announces Oral Presentation of MDNA11 Data from the Phase 1/2 ABILITY-1 Study at the 2024 ASCO Annual MeetingApril 11, 2024 | investing.comMedicenna reports advancement in cancer immunotherapyApril 4, 2024 | finance.yahoo.comMedicenna to Present at the 2024 Bloom Burton & Co. Healthcare Investor ConferenceMarch 1, 2024 | morningstar.comMedicenna Therapeutics Corp MDNAFebruary 14, 2024 | finance.yahoo.comMedicenna Therapeutics Reports Third Quarter Fiscal 2024 Financial Results and Corporate UpdateJanuary 12, 2024 | tmcnet.comMedicenna Announces Appointment of New AuditorDecember 19, 2023 | finance.yahoo.comMedicenna Announces Trading on the OTCQB Under the Symbol MDNAFNovember 20, 2023 | finance.yahoo.comMDNA.TO: Overall Survival Data from Phase 2b Trial of Bizaxofusp Presented at SNO 2023…November 14, 2023 | finance.yahoo.comMedicenna Therapeutics Reports Second Quarter Fiscal 2024 Financial Results and Operational HighlightsNovember 13, 2023 | finance.yahoo.comMDNA.TO: Additional Confirmed PR in Phase 1/2 ABILITY Trial of MDNA11November 6, 2023 | finance.yahoo.comMedicenna Announces Promising Single-Agent Response and Durability of MDNA11 in the Phase 1/2 ABILITY Study During Dose Escalation at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)November 3, 2023 | finance.yahoo.comMedicenna Presents Preclinical Data on MDNA113, its Targeted Metalloprotease Activated SuperKine (T-MASK) at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)October 30, 2023 | msn.comWhy Is Medicenna Therapeutics (MDNA) Stock Down Today?October 27, 2023 | finance.yahoo.comMedicenna Announces Nasdaq Delisting and Cutback of Management TeamOctober 25, 2023 | finance.yahoo.comMedicenna Therapeutics Doses First Patient in Phase 2 Monotherapy Dose Expansion Portion of the ABILITY Study Evaluating MDNA11 in Select Types of Solid TumorsOctober 13, 2023 | theglobeandmail.comClosing Bell: Medicenna Therapeutics Corp up on Thursday (MDNA)October 10, 2023 | markets.businessinsider.comMedicenna Therapeutics Names Humphrey Gardner CMOOctober 10, 2023 | finance.yahoo.comMedicenna Therapeutics Appoints Humphrey Gardner, M.D., as Chief Medical OfficerSeptember 28, 2023 | finance.yahoo.comMedicenna Announces Results of Annual and Special Meeting of ShareholdersSeptember 13, 2023 | nasdaq.comMedicenna Therapeutics (TSE:MDNA) Price Target Decreased by 12.14% to 3.94August 22, 2023 | theglobeandmail.comClosing Bell: Medicenna Therapeutics Corp flat on Monday (MDNA)August 15, 2023 | msn.comMDNA: Commences Monotherapy Dose Expansion in Phase 1/2 ABILITY Trial…August 14, 2023 | markets.businessinsider.comThe Latest Analyst Ratings for Medicenna TherapeuticsAugust 14, 2023 | finance.yahoo.comMedicenna Establishes Boston Presence, Appoints Brent Meadows as Chief Business Officer, and Bolsters ManagementAugust 8, 2023 | benzinga.comMedicenna Therapeutics's Earnings: A PreviewAugust 8, 2023 | benzinga.comMedicenna Appoints Dr. Arash Yavari as Chair of Development Advisory CommitteeAugust 8, 2023 | finance.yahoo.comMedicenna Appoints Dr. Arash Yavari as Chair of Development Advisory CommitteeAugust 4, 2023 | finance.yahoo.comMedicenna Therapeutics to Provide Clinical Update from Phase 1/2 ABILITY Study on August 9, 2023August 1, 2023 | finance.yahoo.comMedicenna Strengthens IP Portfolio with U.S. Patent Granted for the Use of Interleukin-2 Superkine Fusion Proteins in OncologyJuly 31, 2023 | markets.businessinsider.comH.C. Wainwright Thinks Medicenna Therapeutics Corp’s Stock is Going to RecoverJuly 28, 2023 | finanznachrichten.deMedicenna Therapeutics Corp.: Medicenna Reports First Quarter Fiscal 2024 Financial Results and Operational HighlightsJuly 28, 2023 | finance.yahoo.comMedicenna Reports First Quarter Fiscal 2024 Financial Results and Operational HighlightsJuly 25, 2023 | finance.yahoo.comMedicenna Presents at National Brain Tumor Society's Research Round TableJuly 19, 2023 | theglobeandmail.comClosing Bell: Medicenna Therapeutics Corp down on Tuesday (MDNA)July 6, 2023 | finance.yahoo.comMDNA: Full MDNA11 Clinical Update in Calendar 3Q23…June 27, 2023 | finanznachrichten.deMedicenna Therapeutics Corp.: Medicenna Reports Fiscal Year 2023 Financial Results and Operational HighlightsJune 27, 2023 | finance.yahoo.comMedicenna Reports Fiscal Year 2023 Financial Results and Operational HighlightsMay 18, 2023 | theglobeandmail.comClosing Bell: Medicenna Therapeutics Corp down on Wednesday (MDNA)May 16, 2023 | theglobeandmail.comClosing Bell: Medicenna Therapeutics Corp down on Monday (MDNA)May 6, 2023 | theglobeandmail.comClosing Bell: Medicenna Therapeutics Corp flat on Friday (MDNA)April 29, 2023 | theglobeandmail.comClosing Bell: Medicenna Therapeutics Corp down on Friday (MDNA)April 27, 2023 | finance.yahoo.comMedicenna Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price RequirementApril 22, 2023 | theglobeandmail.comClosing Bell: Medicenna Therapeutics Corp up on Friday (MDNA)April 19, 2023 | msn.comMDNA: Update on ABILITY Trial…April 19, 2023 | finance.yahoo.comHere's Why We're Not Too Worried About Medicenna Therapeutics' (TSE:MDNA) Cash Burn Situation Get Medicenna Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for MDNA and its competitors with MarketBeat's FREE daily newsletter. Email Address We just added a $300 account credit to your MarketBeat subscription (Ad)MarketBeat All Access is our complete suite of portfolio monitoring software, research tools, stock screeners, proprietary reports, and more. Upgrade today and get $300 off your 2024-2025 subscription. Free for 30 days. Start Your Risk-Free Trial Here MDNA Media Mentions By Week MDNA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MDNA News Sentiment▼0.000.62▲Average Medical News Sentiment MDNA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MDNA Articles This Week▼10▲MDNA Articles Average Week Get Medicenna Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for MDNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: DRRX News PMN News FBIO News AADI News YS News ACXP News LEXX News IMRX News LPCN News XLO News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MDNA) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medicenna Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medicenna Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
